Cargando…
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited testing policies to confirm SARS-CoV-2 infection. Recently, it was shown that it is possible to predict COVID-19 cases using cross-sectional self-reported disease-related symptoms. Here, we demonstrate...
Autores principales: | van Blokland, Irene V., Lanting, Pauline, Ori, Anil P. S., Vonk, Judith M., Warmerdam, Robert C. A., Herkert, Johanna C., Boulogne, Floranne, Claringbould, Annique, Lopera-Maya, Esteban A., Bartels, Meike, Hottenga, Jouke-Jan, Ganna, Andrea, Karjalainen, Juha, Hayward, Caroline, Fawns-Ritchie, Chloe, Campbell, Archie, Porteous, David, Cirulli, Elizabeth T., Schiabor Barrett, Kelly M., Riffle, Stephen, Bolze, Alexandre, White, Simon, Tanudjaja, Francisco, Wang, Xueqing, Ramirez, Jimmy M., Lim, Yan Wei, Lu, James T., Washington, Nicole L., de Geus, Eco J. C., Deelen, Patrick, Boezen, H. Marike, Franke, Lude H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357137/ https://www.ncbi.nlm.nih.gov/pubmed/34379666 http://dx.doi.org/10.1371/journal.pone.0255402 |
Ejemplares similares
-
Lifelines COVID-19 cohort: investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohort
por: Mc Intyre, Katherine, et al.
Publicado: (2021) -
Increased genetic contribution to wellbeing during the COVID-19 pandemic
por: Warmerdam, C. A. Robert, et al.
Publicado: (2022) -
Idéfix: identifying accidental sample mix-ups in biobanks using polygenic scores
por: Warmerdam, Robert, et al.
Publicado: (2021) -
Correction for both common and rare cell types in blood is important to identify genes that correlate with age
por: Pellegrino-Coppola, Damiano, et al.
Publicado: (2021) -
HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination
por: Bolze, Alexandre, et al.
Publicado: (2022)